OCGN posts a wider Q2 loss as R&D spending climbs, while advancing late-stage gene therapy programs

Ocugen NASDAQ: OCGN said its second quarter marked progress across its late-stage ophthalmology pipe

Ocugen, Inc. (OCGN) Q2 2026 Earnings Call Transcript

Ocugen (OCGN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate

Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.07) per share which missed the analyst consens

Conference Call and Webcast Today at 8:30 a.m. ET Received U.S. Food and Drug Administration (FDA) c

MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN),

RMAT designation is intended to help expedite development of new regenerative medicines that have po

MALVERN, Pa, July 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCG

MALVERN, Pa. , July 28, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN)

Cumulative sales milestones up to $255 million and modest upfront/near-term development milestonesRo

Cumulative sales milestones up to $255 million and modest upfront/near-term development milestones R

Ocugen NASDAQ: OCGN outlined plans to advance three late-stage retinal disease programs, with compan

MALVERN, Pa. , July 01, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN)

Ocugen (OCGN) reported earnings 30 days ago. What's next for the stock?

OCGN is advancing gene-agnostic eye therapies across retinal diseases, with key trial data and regul

Ocugen faces cash burn and dilution risks, but upcoming eye gene therapy data and planned filings th

Ocugen's three ocular gene therapy programs could deliver trial data, filings, and potential BLA mil

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN),

MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN),

The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking th

Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance

Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acqu

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company report

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

  During Tuesday's session, 275 companies made new 52-week lows.

The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it i

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 250 points on W

  On Wednesday, 129 stocks made new 52-week lows.

Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly e

  On Wednesday, 345 companies set new 52-week lows.

  Tuesday's session saw 286 companies set new 52-week lows.

  On Monday, 147 stocks made new 52-week lows.

  On Wednesday, 220 stocks hit new 52-week lows.

  On Friday, 93 stocks made new 52-week lows.

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for

  On Tuesday, 298 companies achieved new lows for the year.

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a

  On Tuesday, 838 companies hit new 52-week lows.